Among these, the P2X4 receptor (P2X4R), able to bind to eATP, stands out as particularly promising, with increasing evidence linking its involvement to the pathogenesis of various tumor types, including GBM (Figure 3). This evidence concerns the gene P2RX4 and glioblastoma.